KRAS and cancer: Further, a comprehensive Gene Set Variation Analysis (GSVA) was conducted across 50 hallmark pathways (Figure 7), revealing a strong association between TUBA1B expression and pathways that drive cancer progression, such as hypoxia, KRAS, P53, and MYC signaling.